1
7.50–7.41 (4H, m), 4.51 (2H, q, J 7.1, OCH2CH3), 1.43 (3H, t,
1546, 1265, 741. H NMR: dH 8.12 (2H, dd, J 5.4, J 1.2), 8.00
(1H, dt, J 7.8, J 1.8), 7.80 (1H, d, J 2.3), 7.66 (1H, dt, J 7, J 1.2),
7.51 (1H, dt, J 8.1, J 0.9), 7.37–7.31 (1H, m), 7.25–7.07 (2H, m),
6.10 (1H, s), 4.04 (1H, sept, J 6.6), 1.23 (3H, d, J 6.6). 13C NMR:
dC 167.1, 161.7, 161.1 (d, 1J 249), 149.1, 143.0, 131.8 (d, 4JCF 2.5),
•
J 7.1, OCH2CH3). MS (EI, GC–MS) m/z 295 (M+ , 100%), 223
(56). HRMS (C18H15FNO2) calc.: 296.1087, found: 296.1078.
1
8k2: H NMR: dH 8.39 (2H, m), 8.17–8.09 (3H, m), 7.50–7.41
•
(4H, m), 3.99 (3H, s, OCH3). MS (EI, GC–MS) m/z 281 (M+ ,
3
100%), 224 (32), 223 (21). HRMS (C17H13FNO2) calc.: 282.0930,
found: 282.0918.
131.5 (d, JCF 8.1), 130.5, 127.9, 127.7, 127.5, 125.4, 125.1 (d,
4JCF 3.7), 123.9, 120.1, 119.9, 116.6 (d, 2JCF 22.6), 42.7, 23.1. 19
F
•
NMR: dF −117.3 (m). MS (EI, GC–MS) m/z 308 (M+ , 93%),
293 (56), 250 (100), 222 (67), 202 (12). HRMS (C19H18FN2O)
calc.: 309.1403, found: 309.1396.
Ethyl- and methyl-6-chloro-2-phenylquinoline-4-carboxylate83
(8l1, 8l2). Using the general procedure, imine 1l (0.4 mmol)
afforded a mixture of esters 8l1 and 8l2 (31 mg, 25%). Attempts
to separate these two esters were unsuccessful, but because of the
product distribution (3 : 1 ratio) the NMR could nevertheless be
resolved. 8l1: 1H NMR: dH 8.83 (1H, s), 8.43 (1H, d, J 4.2), 8.20–
8.12 (3H, m), 7.71–7.68 (1H, m), 7.55–7.32 (3H, m), 4.54 (2H, q,
J 7.1, OCH2CH3), 1.50 (3H, t, J 7.1, OCH2CH3). MS (EI, GC–
(S)-N -(1-Phenylpropyl)-2-phenylquinoline-4-carboxamide
(10a)1. White solid (67 mg, 47%), mp 158 ◦C (lit.1: 140–141 ◦C)
[a]D20 = −24.2 (c 0.5, MeOH, lit.1 [a]D20 = −26.7). H NMR: dH
1
8.03–8.00 (2H, m), 7.99 (1H, dd, J 7.6, J 0.8), 7.69 (1H, s), 7.63
(1H, dt, J 5.5, J 1.5), 7.46–7.31 (10H, m), 6.80 (d, 1H, J 8.4),
5.16 (1H, q, J 8.1), 0.98 (3H, t, J 8.1). 13C NMR: dC 167.4,
157.0, 148.9, 143.4, 141.9, 139.2, 130.4, 130.1, 129.1, 128.1,
127.9, 127.6, 127.2, 126.9, 125.3, 123.7, 116.6, 56.1, 29.5, 11.6.
•
MS) m/z (tR = 25.1 min) 311 (M+ , 100%), 297 (10), 239 (81),
241 (29), 240 (21), 204 (17), 203 (20). HRMS (C18H14ClNO2)
calc.: 312.0791, found: 312.0791. 8l2: 1H NMR: dH 8.83 (1H, s),
8.43 (1H, d, J 4.2), 8.20–8.11 (3H, m), 7.71–7.68 (1H, m), 7.55–
7.32 (3H, m), 4.07 (3H, s, OCH3). MS (EI, GC–MS) m/z (tR =
(S)-N-(1-Phenylpropyl)-2-(2ꢀ -fluorophenyl)-quinoline-4-car-
boxamide (10b). White solid (53 mg, 35%), mp 160 ◦C. [a]D20
=
•
24.1 min) 297 (M+ , 100%), 241 (26), 240 (23), 239 (82), 204 (15).
−46 (c 1, MeOH). IR mmax/cm−1 (KBr): 3260, 2964, 1705, 1641,
1555, 1467, 1260. 1H NMR: dH 8.16–8.07 (3H, m), 7.88 (1H, s),
7.72 (1H, t, J 2.1), 7.52 (1H, d, J 1), 7.36–7.14 (7H, m), 6.49
(1H, d, J 8.3), 5.16 (1H, q, J 7.5), 2.01–1.90 (2H, m), 0.85 (3H,
HRMS (C17H13ClNO2) calc.: 298.0635, found: 298.0654.
Ethyl-84 and methyl-6-bromo-2-phenylquinoline-4-carboxy-
late84 (8m1, 8m2). Using the general procedure, imine 1m
(0.4 mmol) afforded a mixture of esters 8m1 and 8m2 (78 mg,
52%). Attempts to separate these two esters were unsuccessful,
but because of the product distribution (3 : 1 ratio) the NMR
could nevertheless be resolved. 8m1: 1H NMR: dH 9.00 (1H, d, J
2.1, H5), 8.43 (1H, s, H3 arom), 8.21–8.17 (2H, m), 8.06 (1H, s),
7.85 (1H, d, J 1.2, H8 arom), 7.58–7.49 (2H, m), 7.35–7.21 (2H,
m), 4.55 (2H, q, J 7.1, OCH2CH3), 1.51 (3H, t, J 7.1, OCH2CH3).
t, J 7.5). 13C NMR: dC 165.4, 159.3 (d, JCF 249), 152.1, 147.3,
1
3
140.9, 140.1, 129.9 (d, JCF 8.1), 129.7, 128.7, 128.6, 127.4,
4
127.2, 126.2, 125.2, 123.6, 123.3 (d, JCF 3.7), 122.1, 118.1
(d, JCF 8.1), 114.8 (d, JCF 22.6), 54.1, 27.7, 9.1. 19F NMR:
3
2
•
dF −105.6 (m). MS (EI, GC–MS) m/z 384 (M+ , 12%), 355
(16, M − CH2CH3), 270 (33), 255 (23), 250 (48), 222 [35, M −
CONHCH(PhCH2CH3)], 99 (100). HRMS (C25H21FN2O) calc.:
384.1638, found: 384.1620.
•
MS (EI, GC–MS) m/z (tR = 27.1 min) 357 (M+ , C18H1481BrNO2,
•
100%), 355 (M+ , C18H1479BrNO2, 99%), 285 (81), 284 (77), 203
(S)-N-(1-Phenylpropyl)-2-(4ꢀ -fluorophenyl)-quinoline-4-car-
(28). HRMS (C18H1579BrNO2) calc.: 356.0286, found: 356.0283.
8m2: 1H NMR: dH 9.00 (1H, d, J 2.1, H5), 8.45 (1H, s, H3 arom),
8.21–8.17 (2H, m), 8.09 (1H, s), 7.81 (1H, d, J 1.2, H8 arom),
7.58–7.49 (2H, m), 7.35–7.21 (2H, m), 4.07 (3H, s, OCH3). MS
boxamide (10j). White solid (74 mg, 48%), mp 160 ◦C. [a]D20
=
−27 (c 1, MeOH). IR mmax/cm−1 (KBr): 3053, 2986, 1701, 1670,
1421, 1264, 738. 1H NMR: dH 8.00–7.94 (3H, m), 7.61 (1H, s),
7.38–7.24 (6H, m), 7.13 (2H, t, J 8.6), 6.76 (1H, d, J 8.3), 5.15
(1H, q, J 7.6), 2.00–1.89 (2H, m), 0.98 (3H, t, J 7.6). 13C NMR:
•
(EI, GC–MS) m/z (tR = 26.0 min) 343 (M+ , C17H1281BrNO2,
•
96%), 341 (M+ , C17H1279BrNO2, 68%), 285 (99), 284 (87), 203
1
dC 167.3, 164.3 (d, JCF 249), 155.8, 148.8, 143.3, 141.9, 135.2
(d, JCF 3.1), 130.5, 130.3, 129.7 (d, JCF 8.2), 129.2, 129.1,
(40). HRMS (C17H1379BrNO2) calc.: 342.0130, found: 342.0123.
4
3
2
128.1, 127.6, 127.2, 125.2, 123.5, 116.3, 116.2 (d, JCF 21.4),
56.2, 29.8, 11.8. 19F NMR: dF −112.1 (m). MS (EI, GC–MS)
General procedure for the preparation of
2-arylquinoline-4-carboxamides
•
m/z 384 (M+ , 25%), 363 (31), 355 (31, M − CH2CH3), 250
(100), 222 [69, M − CONHCH(PhCH2CH3)], 190 (64). HRMS
A solution of imine 1a (72 mg, 0.4 mmol) and amide 3 (219 mg,
1 mmol) or 4 (159 mg, 1 mmol) was added to indium chloride
(88 mg, 0.4 mmol) in acetonitrile (2 mL) in a reaction tube. The
solution was heated in a microwave oven (150 W) for 3 min. The
mixture was cooled to room temperature, poured into water
(20 mL) and extracted with dichloromethane (20 mL). The
organic layers were combined, washed with brine, dried over
MgSO4 and evaporated under vacuum. The crude product was
purified by column chromatography over silica gel (pentane–
ethyl acetate 95 : 5 to 80 : 20) to yield the expected quinoline
4-carboxamide.
(C25H21FN2O) calc.: 384.1638, found: 384.1652.
(S)-N -(1-Phenylpropyl)-6-fluoro-2-phenylquinoline-4-car-
boxamide (10k). White solid (75 mg, 49%), mp 160 ◦C. [a]D20
=
−24.8 (c 1, MeOH). IR mmax/cm−1 (KBr): 3258, 2964, 1705,
1
1641, 1555, 1467, 1260. H NMR: dH 8.03–7.97 (3H, m), 7.70
(1H, s), 7.62–7.50 (1H, dd, J 6.9, J 2.8), 7.50–7.26 (9H, m),
6.57 (1H, d, J 8.4), 5.19 (1H, q, J 7.5), 2.06–1.97 (2H, m), 1.01
(3H, t, J 7.5). 13C NMR: dC 166.5, 160.1 (d, JCF 249), 156.0,
1
3
145.8, 142.2, 141.4, 138.5, 132.4 (d, JCF 9.4), 129.8, 128.9,
2
128.8, 128.6, 128.0, 127.8, 127.3, 126.8, 126.6, 120.4 (d, JCF
25.8), 116.8, 108.8 (d, 2JCF 23.4), 55.8, 24.4, 10.9. 19F NMR: dF
•
−111.5 (m). m/z (EI, GC–MS) 384 (M+ , 12%), 355 (16, M −
N-Isopropyl-2-phenylquinoline-4-carboxamide (9a). Yellow
solid (66 mg, 57%), mp 148–150 ◦C. IR mmax/cm−1 (KBr): 3270,
2990, 2950, 1634, 1595, 1570, 785. 1H NMR: dH 8.22–8.15
(4H, m), 7.88 (1H, s), 7.76 (1H, t, J 6.0), 7.58–7.50 (4H, m),
5.91 (1H, br s), 4.46 (1H, sept, J 6.7), 1.36 (6H, d, J 6.7).
13C NMR: dC 171.1, 166.8, 154.2, 148.7, 143.9, 138.9, 130.1,
129.7, 128.9, 127.9, 124.9, 123.4, 116.4, 41.9, 22.4. MS (EI)
CH2CH3), 333 (14), 288 (15), 270 (33), 250 (48), 222 [31, M −
CONHCH(PhCH2CH3)], 99 (100). HRMS (C25H22FN2O) calc.:
385.1716, found: 385.1705.
(S)-N-(1-Phenylpropyl)-2-(3ꢀ -fluorophenyl)-quinoline-4-car-
boxamide (10n). White solid (81 mg, 53%), mp 160 ◦C. [a]D20
=
•
−27.6 (c 1 in MeOH). IR mmax/cm−1 (KBr): 3260, 3060, 1705,
m/z 290 (M+ , 100%), 275 (M − CH3, 48%), 247 (11), 232
1
1641, 1467, 1353, 1260. H NMR: dH 8.05 (1H, d, J 8.4), 7.95
[65, M − NHCH(CH3)2], 204 [33, M − CONHCH(CH3)2], 176
(1H, d, J 7.8), 7.82–7.77 (2H, m), 7.70–7.66 (2H, m), 7.46–7.15
(8H, m), 6.68 (1H, d, J 7.7), 5.19 (1H, q, J 7.7), 2.13–2.04 (2H,
m), 1.02 (3H, t, J 7.7). 13C NMR: dC 164.4, 160.5 (d, 1JCF 246),
(12). HRMS (C19H19N2O) calc.: 291.1497, found: 291.1487.
N-Isopropyl-2-(2ꢀ-fluorophenyl)-quinoline-4-carboxamide (9b).
Yellow oil (53 mg, 43%). IR mmax/cm−1 (NaCl): 3058, 1634, 1610,
3
153.0, 152.9, 146.3, 141.0, 139.3, 138.9, 128.1 (d, JCF 10.7),
3 8 0 2
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 3 7 9 4 – 3 8 0 4